BRIEF published on 04/13/2026 at 08:05, 5 months 19 days ago Transgene conclut la randomisation des patients dans la phase 2 de l'essai clinique TG4050 Cancer De La Tête Et Du Cou Essai Clinique De Phase 2 Transgene Vaccin TG4050 Survie Sans Maladie
BRIEF published on 04/13/2026 at 07:35, 5 months 19 days ago Infoclip annonce un projet de changement de contrôle Offre Publique De Retrait Changement De Contrôle Infoclip RIVAGE GROUPE Laurent Azoulay
BRIEF published on 04/13/2026 at 07:35, 5 months 19 days ago Infoclip announces a proposed change of control Change Of Control Public Delisting Offer Infoclip Laurent Azoulay RIVAGE GROUP
BRIEF published on 04/13/2026 at 07:05, 5 months 19 days ago Burkhalter Group's Robust 2025 Financial Performance Surpasses Expectations Financial Performance Acquisitions Dividend Increase Market Outlook Sustainability Initiatives
BRIEF published on 04/13/2026 at 07:05, 5 months 19 days ago Les solides performances financières du groupe Burkhalter en 2025 dépassent les attentes. Acquisitions Performance Financière Perspectives Du Marché Augmentation Des Dividendes Initiatives De Développement Durable
BRIEF published on 04/13/2026 at 07:05, 5 months 19 days ago Swiss Re Releases 2025 Financial Condition Report Reinsurance Risk Management Swiss Re Financial Condition Solvency
BRIEF published on 04/13/2026 at 07:05, 5 months 19 days ago Swiss Re publie son rapport sur la situation financière pour 2025 Réassurance Swiss Re Gestion Des Risques Situation Financière Solvabilité
BRIEF published on 04/13/2026 at 07:05, 5 months 19 days ago 20 Years of Biosimilar Medicines: Sandoz Celebrates a Milestone Biosimilars Healthcare Savings Patient Access Omnitrope Patent Expiries
BRIEF published on 04/13/2026 at 07:05, 5 months 19 days ago 20 ans de médicaments biosimilaires : Sandoz célèbre une étape importante Biosimilaires Accès Des Patients Omnitrope Économies En Soins De Santé Expiration Des Brevets
BRIEF published on 04/13/2026 at 07:05, 5 months 19 days ago BioVersys Advances Tuberculosis Treatment with AlpE Drug Resistance BioVersys Tuberculosis Alpibectir Ethionamide
Published on 10/02/2026 at 13:50, 4 hours 45 minutes ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 5 hours 35 minutes ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 5 hours 35 minutes ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/02/2026 at 13:00, 5 hours 35 minutes ago Datavault AI CEO to Present "Operating System for Tokenized Assets" at XRP Seoul 2026
Published on 10/02/2026 at 18:00, 35 minutes ago EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 18:00, 35 minutes ago AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 18:00, 35 minutes ago AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)
Published on 10/02/2026 at 17:45, 50 minutes ago Linedata Services: Assemblée Générale Extraordinaire Modalités de mise à disposition des documents préparatoires
Published on 10/02/2026 at 17:45, 50 minutes ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 50 minutes ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 1 hour ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 1 hour 5 minutes ago Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 1 hour 5 minutes ago Aéroports de Paris SA - Calendrier financier 2027
